Historical record - last NADAC effective date: 8/23/2023

Product Information

CELECOXIB 200 MG CAPSULE is a generic product labeled by Yiling Pharmaceutical Inc., priced at $0.1227 per EA under NDC 69117002202. Its NADAC has been published 57 times since Jul 27, 2022.

FDA first approved this application on Mar 6, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CELECOXIB 200 MG CAPSULE

Celecoxib
$0.1227per EA

Strength

200 mg/1

NDC

69117002202

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/23/2023

Active Ingredients

CELECOXIB

Approval Type

Generic (ANDA)

FDA Application

ANDA211412

FDA Approved

3/6/2020

TE Code

AB

On Market Since

3/6/2020

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for CELECOXIB 200 MG CAPSULE has been published 57 times since Jul 27, 2022, and over the history we have for it it has declined 4.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1227 per EA
All-time high$0.1311 (Nov 16, 2022)
All-time low$0.1036 (Jun 21, 2023)
Median price$0.1109
Average price$0.1162
Largest weekly change+14.7% (Aug 23, 2023)
Weeks tracked57
Tracking sinceJul 27, 2022

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

+14.7%

5Y

N/A

All

-4.6%

Last surveyed Aug 23, 2023 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of CELECOXIB 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 200 MG CAPSULE, manufactured by Yiling Pharmaceutical Inc., is $0.1227 per EA (NDC 69117002202), effective Aug 23, 2023.

How has the price of CELECOXIB 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CELECOXIB 200 MG CAPSULE has declined 4.6%. It has been tracked across 57 weekly CMS publications since Jul 27, 2022.

What are the highest and lowest recorded NADAC prices for CELECOXIB 200 MG CAPSULE?

Since Jul 27, 2022, the NADAC for CELECOXIB 200 MG CAPSULE has ranged from a low of $0.1036 (Jun 21, 2023) to a high of $0.1311 (Nov 16, 2022), with a median of $0.1109 per EA.

Are there cheaper alternatives to CELECOXIB 200 MG CAPSULE?

Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CELECOXIB 200 MG CAPSULE, is $0.0760 per EA — about 38% below CELECOXIB 200 MG CAPSULE.

Who manufactures CELECOXIB 200 MG CAPSULE?

CELECOXIB 200 MG CAPSULE (NDC 69117002202) is labeled by Yiling Pharmaceutical Inc., and CMS classifies it as a generic product.